In many chronic diseases, the patient's health status is followed up by quantitative markers. The evolution is often characterized by a 2-phase degradation process, that is, a normal phase followed by a pathological degradation phase preceding the disease diagnosis. We propose a joint multistate model with latent state for the joint modeling of repeated measures of a quantitative marker, time-to-illness and time-to-death. Using data from the PAQUID cohort on cognitive aging, we jointly studied cognitive decline, dementia risk, and death risk. We estimated the mean evolution of cognitive scores given age at dementia for subjects alive and demented, the mean evolution of cognitive scores for subjects alive and nondemented, in addition to age at acceleration of cognitive decline and duration of the pre-dementia phase.
INTRODUCTION
Many chronic diseases such as cancer, HIV, and Alzheimer's disease involve a long-term process often beginning before the disease diagnosis. The subjects go successively through several states from normal to severe disease, and the disease diagnosis can be considered as one of these states. Moreover, the patient's health status may be followed up by one or several quantitative markers such as prostate-specific antigen for prostate cancer, CD4 T-cell counts for HIV, or cognitive tests for Alzheimer's disease. Multistate models (Hougaard, 1999) may be used to describe the development of such diseases, but they do not describe the time course of the biomarkers. During the last 10 years, joint models have been developed to study the relationship between a longitudinal response process and time-to-event (Tsiatis and Davidian, 2004) . Some joint models have been proposed for a longitudinal biomarker and several time-to-events, either for recurrent events (Han and others, 2007) or for competing risks (Elashoff and others, 2008) . However, to our knowledge, there has been no attempt at combining multistate models and mixed models for longitudinal data in order to study the links between biomarker evolution and the risk of transition between the different states of the disease.
Among the chronic diseases, Alzheimer's disease is characterized by a very long pre-diagnosis decline with a 2-phase degradation process of cognitive functions (Amieva and others, 2008) and large interindividual variability. Knowledge of the pre-diagnosis phase is a real public health challenge both described by a segmented mixed model with a linear trend before and after the changepoint:
with i j ∼ N (0, σ 2 ) and b 11i the slope of cognitive decline in the healthy phase and b 12i the slope of cognitive decline in the pre-diagnosis phase. To ensure the continuity at changepoint τ i , we impose the constraint b 02i = b 01i + (b 11i − b 12i )τ i . Using the parameter transformation recommended by Bacon and Watts (1971) for numerical stability,
the model is rewritten as Y i j = β 0i + β 1i (t i j − τ i ) + β 2i (t i j − τ i )sgn(t i j − τ i ) + i j with the function sgn(t) = −1 if t < 0 and sgn(t) = 1 if t 0. Thus, β 0i corresponds to the mean marker value at the random changepoint, β 1i is the mean of the 2 slopes, and β 2i is half the difference between the slopes. These coefficients are modeled as the sum of a mean effect that may depend on fixed covariates and an individual random effect:
for k = 0, 1, 2. The vector u i = (u 0i , u 1i , u 2i ) of random effects is N (0, G). In (2.1), u 1i is a random effect on the mean slopes, whereas u 2i is a random effect on half the difference of the 2 slopes. The following alternative formulation of the model allows to introduce separately random slopes in the first 726 E. DANTAN AND OTHERS phase (u s 1 i ) and in the second phase (u s 2 i ):
Thus, for instance, this model formulation makes possible to keep in the model a random slope for the prediagnosis phase while excluding the random slope in the healthy phase as we have previously observed that the variability in the pre-diagnosis phase is higher than in the healthy phase (Jacqmin- Gadda and others, 2006) . In this formulation, the random-effect vector is
Finally, clinical observations do not suggest an abrupt change in the rate of decline between the 2 phases but rather a smooth transition. To insure this smooth transition, the function sgn(t) is replaced by the function trn(t; γ ) = 1 t t 2 + γ (Seber and Wild, 2003) :
This trn function also insures the continuity of the first and second derivatives at τ i with respect to all parameters in the mixed model that is required for using Newton-Raphson-like algorithm for the parameter estimation. As lim γ →0 trn(t; γ ) = sgn(t) for small γ , the expectation of Y may be approximated by
As we assume a linear-linear trend for Y (t), we choose a very small value for γ .
Multistate model
Latent state transition intensity. The distribution of the random changepoint τ i which is the age at entry in the latent pre-diagnosis state (state 1) is defined by a proportional transition intensity model for the transition from healthy state (state 0) to pre-diagnosis state (state 1):
where α 0 01 (t) is the baseline transition intensity and X L a q L -vector of covariates associated with a q Lvector of parameters θ L and the age t as timescale. The cumulative transition intensity to the latent state at time t is
We assume independance between τ i and the random effects u i because identifiability problems were observed in the Jacqmin-Gadda and others (2006) model when the random changepoint depended on the random slopes. The main clinical consequence behind this constraint is that the slope of cognitive decline in the pre-diagnosis phase does not depend on the age at entry in this phase after adjustment on covariates (educational level for instance). Given that this pre-diagnosis slope may depend on the slope before τ i (u s 1 i ) and on the cognitive level at τ i (u 0i ), we think the assumption of independence with τ i is reasonnable.
Illness transition intensity. The illness risk is assumed to be null before entering in the pre-diagnosis state and then increase with the time spent in the pre-diagnosis phase. The transition intensity from the pre-diagnosis state (state 1) to the illness state (state 2) follows a proportional transition intensity model that depends on both the time since entry in state 1 (t − τ i ) as timescale and possibly on random effects.
where α 0 12 (t − τ i ) is the baseline transition intensity, X ei a q e -vector of covariates associated with a q evector of parameters θ e , and ν a k-vector of parameters associated with the random effects u i . Thus, the cumulative transition intensity from state 1 to state 2 is
As we assume that direct transition from state 0 to state 2 is impossible, the illness intensity function is defined as
and the corresponding cumulative transition intensity as
Death transition intensity. The transition intensity to death state (state 3) is assumed to be independent of the current patient state (healthy, pre-diagnosis, or illness) conditionally on the current expected biomarker valueỸ (t|τ i , u i ). This assumption is discussed in Section 5. We assume that a proportional transition intensity model describes the death transition intensity as a function of age,Ỹ (t|τ i , u i ) and a q d -vector of covariates X di :
where α 0 3 (t) is the baseline transition intensity for death andỸ i (t|τ i , u i ) is defined in (2.4). The cumulative transition intensity to death is
ESTIMATION Let us define
with T * di the death age and C di the censoring age for death. Similarly, we define (T ei , δ ei ) where
ei <T di }} with T * ei the age at illness diagnosis and C ei the censoring age for this event. Note that the censoring time for illness diagnosis may be different from the censoring time for death since a face-to-face interview is required for the disease diagnosis while age at death is exactly observed. Parameters are estimated using a maximum likelihood approach under the following additional assumptions:
1. Missing values of the marker not due to the disease or the death are missing at random. 2. Censoring for death is not informative (in practice, this is often an administrative censoring corresponding to the end of the study). 3. For subjects alive, censoring for illness diagnosis is not informative. Given the model definition, the competitive risk due to death is taken into account.
We assume parametric baseline transition intensities α 0 01 (t), α 0 12 (t − τ i ) and α 0 3 (t) and denote θ the vector of all regression parameters in (2.3), (2.5-2.7) and variance-covariance parameters (G and σ 2 ). Parameter γ of the function trn is fixed by the user to a small value. Since the 3 outcomes (the marker Y i , the illness age T ei , and the death age T di ) are independent given τ i and u i , the individual contribution to the likelihood is developed as follows:
where f u (u i ) is a multivariate Gaussian density with mean 0 and variance G and f τ (τ i ) the density for τ i :
The function f Y (Y i |τ i , u i ) is a multivariate Gaussian density with mean and variance given by
This likelihood is developed in the Web Supplementary Material A of the supplementary material available at Biostatistics online using a multistate model approach that is by distinguishing all the different trajectories between the 4 states. In particular, we account for the fact that, due to interval censoring of the disease, a subject who was free of disease at the last visit and then died may have passed by the state illness between the last visit and the death. Then it is demonstrated that the corresponding terms in the likelihood vanish, and we obtain likelihood (3.1) thanks to the independence between the risk of death and the state conditionally on the current marker value. Thus, the main bias associated with interval censoring of illness diagnosis is addressed without complicating the likelihood. Most studies include only subjects alive and not already diagnosed at the beginning of the study. This induces left truncation that must be taken into account in the likelihood by dividing the latter by the joint probability to be alive and illness-free at the age of entry into the study T 0i :
Parameters were estimated by the maximum likelihood using a Newton-Raphson-like optimization algorithm detailed in the Web Supplementary Material B of the supplementary material available at Biostatistics online and Gaussian quadrature for computing the integrals. Variance of the estimates were obtained by the inverse of the observed Hessian matrix at convergence. A simulation study presented in the Web Supplementary Material C of the supplementary material available at Biostatistics online showed the good behavior of these estimates. In particular, they were less biased than estimates obtained by considering death as a noninformative censoring.
APPLICATION

The PAQUID data set
The PAQUID cohort is a French prospective study on cognitive aging including 3777 subjects aged 65 years and older and living at home at the initial visit. Subjects were initially interviewed at home in 1988 and 1, 3, 5, 8, 10, 13, and 15 years later. Initial measurements were excluded because of the learning effect previously described between the first 2 exams (Jacqmin-Gadda and others, 1997). Dementia diagnosis is assessed at each visit by the investigating psychologist and then confirmed by clinical examination by a neurologist if the subjects were screened positive by the psychologist. The time basis used for the analyses is age. Dementia age is computed as the mean between the age at dementia diagnosis and the age at the last visit without dementia. Age of censoring for dementia is the age at the last follow-up visit for the subject. As we aimed at estimating pre-diagnosis cognitive decline, the cognitive measures collected after the diagnosis were excluded. This exclusion was also justified by the high rate of missing cognitive measures after dementia diagnosis in Paquid, and by the fear that the assumption of a long-term linear trend postdiagnosis was not appropriate. We also excluded 102 subjects diagnosed as demented at baseline. Thus, the left truncation has to be taken into account. Vital status was collected on every participant (including refusals and dropouts) by phone contact and, if necessary, age at death was obtained from the general practitioner. Age at death was censored at the end of follow up, that is, age at entry plus 15.
The psychometric test used was the Benton Visual Retention Test (Benton, 1965) which evaluates visual memory with scores ranging from 0 to 15. In this analysis, we compared the characteristics of the pre-diagnosis phase according to the educational level considered in 2 categories: no education or primary school level without diploma (denoted PSD−) versus primary school diploma or higher level (denoted PSD+). The samples included 2396 PSD+ and 1279 PSD− nondemented at the initial visit. The mean age of entry into the study was, respectively, 74.5 years and 76.7 years for PSD+ and PSD−. The mean number of measurements before dementia diagnosis was 2.88 for PSD+ (first quartile: 1, median: 2, third quartile: 5) and 1.77 for PSD− (first quartile: 0, median: 1, third quartile: 3). We included subjects with no measure (23% of PSD+ vs. 38% of PSD−) because they contributed to the death risk assessment. During the follow up, 365 PSD+ and 296 PSD− were diagnosed as demented with a mean dementia age of 83.66 years (standard error [SE] = 5.88) and 83.56 years (SE = 5.82); and 1437 PSD+ and 893 PSD− died with a mean age at death of 84.69 years (SE = 7.07) and 86.03 years (SE = 6.68).
Model
The main study was conducted on the 2 separated samples defined by educational level. The baseline transition intensity from state 0 to state 1 and from state 1 to state 2 was defined by Weibull distributions. The baseline intensity for death was a stepwise function with 7 steps (every 5 years). The number of steps was chosen by Akaike information criterion (AIC) between severals models with 5, 6, or 7 steps and different lengths of step. Following results of the simulation study, we decided to use 20 quadrature points for the integration to estimate the models. However, due to computation time, it was not possible to estimate a model with 4 random effects using 20 quadrature points on these samples. Thus, we first selected the best model including only 3 random effects: 5 structures with 2 or 3 random effects were compared by AIC, all including the random changepoint τ i and a random effect on the score level at τ i , β 0i (model 1.a). Models 1.b to 1.e included a third random effect either on the mean slope (model 1.b), or on the difference between the slopes (model 1.c), or on the slope in the second phase (models 1.d and 1.e). In model 1.e, the dementia transition intensity depended on the random slope in the second phase. Finally, the best 3 random-effect model selected by AIC was model 1.d including the random slope for the second phase but no dependence from the dementia transition intensity on this random slope:
with a l > 0, T 1 = 65, T 2 = 70, T 3 = 75, T 4 = 80, T 5 = 85, T 6 = 90 and T 7 = 95.
We reestimated model 1.d with 9 quadrature points and we compared it with the full model including 4 random effects. For PSD−, the 3 random-effect model had a slightly better AIC (AIC = 18 321 for 3 random-effect model vs. AIC = 18 330 for 4 random-effect model), while, for PSD+, the 4 random-effect model had a slightly better AIC (AIC = 41 852 for 3 random-effect model vs. AIC = 41 842 for 4 randomeffect model). However, using the D criteria proposed by Commenges and others (2008) that estimates the Kullback-Leibler distance between the models, these differences in AIC are classified as small for PSD− (D = 2.00 × 10 −3 ) and negligible for PSD+ (D = −7.23 × 10 −4 ). Moreover, parameters estimates and standard errors from the 2 models were close. Thus, we retained the model 1.d with 3 random effects.
Results
From the stratified analysis, the joint model estimates for the 2 educational level are presented in Table 1 . The mean Benton score at entry into the pre-diagnosis state was 10.74 (SE = 0.07) for the PSD+, whereas it was 8.88 (SE = 0.14) for the PSD−. In the healthy phase, cognitive decline was slower for PSD+ ( p 1 = −0.069 points each year, SE = 0.005) than for PSD− ( p 1 = −0.091 points each year, SE = 0.013), whereas the acceleration was greater for PSD+ ( p 2 = −0.68 points each year, SE = 0.034) than for PSD− ( p 2 = −0.41 points each year, SE = 0.034) in the pre-diagnosis phase. The expected age at entry into the pre-diagnosis phase was later for PSD+ (E 01 (t) = 86.13 years, SE = 0.04) than for PSD− (E 01 (t) = 81.11 years, SE = 0.23), while the expected transition time between the pre-diagnosis state and the dementia state was slightly earlier for PSD+ (E 12 (t − τ i ) = 4.93 years, SE = 0.27) than for PSD− (E 12 (t − τ i ) = 5.51 years, SE = 0.37). Figure 2 displays the estimated transition intensities. Figure 2A shows the transition intensity from the healthy state to the pre-diagnosis state is higher for PSD−. Figure 2B shows nonproportionality of transition intensity to dementia state between the 2 educational level (justifying the stratified analysis): the risk is higher for PSD+ before 5 years and lower after. Figures 2C and D displays the transition intensity to death for each educational level given different values of τ i : the median (τ i = 87.04 years for the PSD+ and τ i = 82.12 years for the PSD−), τ i = 65 years to represent a subject always in the pre-diagnosis phase during the follow up, and τ i = 100 years to represent a subject always in the healthy phase. This figure illustrates the association between cognitive state and risk of death. Moreover, the estimated hazard ratio of death for 5 points lost in the Benton score is 1.93 for PSD+ and 2.39 for PSD−. Figure 3 displays the estimated marginal mean scores E(Y (t)) given the age and also the estimated means of Y (t) given that the subject is alive at age t (E(Y (t)|T * d > t)), and given that the subject is 
Fig. 3. Marginal mean scores E(Y (t))
given age for PSD+ (thick dotted line) and PSD− (thick plain line) and several mean trajectories given information on dementia age and death age:
for PSD+ (thin plain line) and for PSD− (thin dashed-dotted line).
alive and nondemented at age t (E(Y (t)|T
). Formulas to estimate these conditional means are given in the Web Supplementary Material D of the supplementary material available at Biostatistics online. The estimated mean score is always higher for PSD+ but the decline is more pronounced compared to oldest PSD−. Another interesting result is that among subjects surviving in oldest ages, the difference in cognitive level between PSD+ and PSD− vanishes. This illustrates once again the strong link between death and cognition and thus the selection phenomenon by death especially among subjects with low education.
For purposes of comparison, we estimated in each sample another model, denoted model 2, that was identical to model 1.d but assuming independence between cognition and time-to-death (η = 0). Estimates were close to those of the model 1.d, but the estimated rate of decline in the pre-diagnosis phase was lower ( p 2 = −0.58 points each year for PSD+, SE = 0.031 and p 2 = −0.34 points each year for PSD−, SE = 0.029), and the time lag between state 1 and state 2 was longer (E 12 (t − τ i ) = 5.29 years, SE = 0.30 for PSD+ and E 12 (t − τ i ) = 6.63 years, SE = 0.43 for PSD−). This is in agreement with the previously reported steeper cognitive decline in late pre-death period (Wilson and others, 2003) .
Goodness-of-fit
We evaluated the fit of the model separately for the 3 outcomes (cognitive scores, age at dementia, and death). First, for nondemented and demented subjects, we compared the means of the posterior score expectationsŶ (t) = E(Y (t)|τ i ,û i ) and the means of the observed cognitive scores using 5-year age intervals (Figure 4) for the 2 educational levels. The random-effect predictionsτ i ,û i were computed by the mode of their posterior distribution given the data Y i , T ei , δ ei , T di , δ di . The Web Figure 1 of the supplementary material available at Biostatistics online displays the observed data and individual trajectories estimated by E(Y (t)|τ i ,û i ) for 16 selected subjects among the 2 groups. These figures show that the model captures well the different evolutions of demented and nondemented subjects and the individual evolution shapes. To evaluate the fit of the death data, we compared the marginal survival function from the joint model estimated by
with the death-survival function estimated using a nonparametric proportional hazard model and a penalized likelihood approach (PHMPL) (Joly and others, 1999 ) (Web Figure 2 of the supplementary material available at Biostatistics online).
To check the parametric assumption regarding baseline transition intensities, it was not possible to compare the estimates for the risk of dementia obtained from the complete model with those obtained with PHMPL because PHMPL considers dead subjects as censored at their last visit. Thus, we compared PHMPL estimates of the dementia survival function with the same function estimated by model 2 (Web Figure 2 of the supplementary material available at Biostatistics online), where dead subjects were treated as censored, using the following formula:
This figure shows an appropriate adjustment for the transition to death and the transition to dementia.
DISCUSSION
We have developed a joint model with latent state for a longitudinal process and illness-death data. Such data are frequent in the monitoring of chronic diseases. This new model makes it possible to describe the pre-diagnosis phase of disease while limiting the bias in parameter estimation. The application shows that the model is particularly well suited for studying cognitive decline in the pre-diagnosis phase. It may be viewed as an improvement on the random changepoint model proposed by Jacqmin-Gadda and others (2006) since it improves the handling of informative right censoring due to death and better accounts for the succession of events in time. In the context of cognitive aging, some authors consider that MCI is a transitional state between healthy and dementia without reversibility (Petersen and others, 1999) , while others thinks it is a risk factor for dementia and may be reversible (Larrieu and others, 2002; Ritchie and others, 2001) . In this work, the pre-diagnosis phase corresponds to the former concept of MCI. Another subject of divergence in the literature regards the cognitive tests and the thresholds used to define MCI. We think it is more rational to define it as a change in the slope of decline instead of a threshold on a cognitive score, as the cognitive levels are highly variable in the population irrespective of any pathological process. The application focused on the role of educational level. Our previous work has shown that prediagnosis cognitive evolution exhibits a clear phase of accelerated decline that is well approximated by a segmented linear-linear model (see Figure 1 in Jacqmin-Gadda and others, 2006). The estimated age at entry into the accelerated decline phase was later in the previous model (90.3 for PSD+ vs. 87.3 years for PSD−), but the meaning of this phase is different in the 2 models. Here, this is an obligatory transition state before dementia (with a null risk of dementia before this state), while, in Jacqmin-Gadda and others (2006) and Yu and Ghosh (2010) , dementia may arise before τ i and the risk of dementia does not increase with the time spent in the second phase. It would be interesting to test the existence of this pre-diagnosis phase of accelerated decline in different populations, for various cognitive tests or according to the type of dementia (Alzheimer vs. vascular dementia for instance). However, the development of such a test would require modeling more flexibly the dependence between risk of dementia and cognitive scores that could be limited by numerical difficulties.
In the proposed joint model, the transition intensities from the 3 transient states to the death state were identical after adjustment on the current cognitive score. With this model, we demonstrate in the Web Supplementary Material A of the supplementary material available at Biostatistics online that the likelihood accounts for possible unobserved transitions to dementia between the last visit and death without any complication. This is important because this is the most serious bias due to intermittent observations. An alternative model would include 3 state-specific transition intensities to death. However, this would seriously complicate the likelihood due to interval censoring of dementia, and convergence problems could be observed if few deaths were observed before the changepoint τ i . Moreover, in our opinion, a model with 3 state-specific transition intensities is less flexible than dependence on the quantitative cognitive score, which changes with time.
While we have checked the parametric assumptions of the model for the PAQUID data, it would be useful to relax some of them. For instance, a cure model allowing a subpopulation to have a null risk of dementia could be investigated as in Yu and Ghosh (2010) . Alternatively, flexible distribution, such as the semi-nonparametric distribution of Gallant and Nychka (1987) , would be interesting for age at entry into the pre-diagnosis phase since the assumption regarding this distribution cannot be evaluated by comparison with observed data. Once again, such extensions are limited by computation time. Improvement in integration and optimization algorithms would be necessary to allow these extensions of the model.
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